The US hematology diagnostics market size is expected to reach US$3.07 billion by 2030, growing at a CAGR of 5.3% from 2024 to 2030.
The increasing incidence of cancer is one of the major factors contributing to the expansion of the market. American Cancer Families, Inc. According to the , in 2021, more than 1.9 million undiagnosed cancer cases have been identified, and more than 600,000 people died from cancer in a single lifetime. Therefore, the demand for cancer diagnosis is expected to increase.
Also, technological advances have revolutionized blood testing techniques, making them more effective and no longer painful for victims. The week of Hematology Diagnostics appears promising due to the large investment in building analysis and thinking about blood-related diseases. With the emerging healthcare expenditure and increasing focus on improving diagnostic facilities, the market for hematology diagnostics is expected to expand significantly within the forecast period.
The emerging incidence of blood related conditions is a significant driving force behind the expansion of hematology diagnostics market in the US. The growth in this market is primarily driven through increasing analysis efforts exploring the effectiveness of hematology diagnostics within the early identification of various. Types of cancer. According to the Leukemia and Lymphoma Family estimates, in 2023, approximately 59,610 people are expected to be diagnosed with leukemia, and there are approximately 1,958,310 undiagnosed cases of leukemia in the US.
US Hematology Diagnostics Marketplace Record Highlights
- By product, consumables ruled the market with a proportion of around 65% in 2023 and are expected to sign the fastest CAGR during the forecast period. Hematology diagnostic consumables are certainly an important component in the daily applications of diagnostic laboratories and health care facilities. Those consumables are integral to carrying out various hematology examinations and procedures that are very important to assist the affected person
- In line with check type, white blood mobile (WBC) check branch accounted for the largest market share in 2023 and is expected to sign the fastest CAGR during the forecast period. The demand for white blood cell (WBC) testing is basically driven by the desire for accurate and suggestive analysis of white and differential counts. This test is a common practice in scientific settings as it plays an important role in diagnosing and tracking a wide range of scientific conditions in the US market.
- In line with the end use, the hospital branch ruled the market in 2023. On the other hand, the diagnostic lab branch is projected to grow at the fastest CAGR during the forecast period. Blood testing laboratories play a very vital role in health care by providing correct and qualified results for the diagnosis and management of blood problems, infections and alternative condition conditions. They help healthcare providers make informed choices about patient support based on test results. All elements will put pressure on the expansion of the market branch
- In 2021, Illumina introduced the TruSight Hematology Panel, a next-generation sequencing (NGS) panel designed to detect hematological problems. This leading answer allows thorough genetic research, which provides good insights for prognosis and treatment
Corporation Featured
- abbott
- Beckman Coulter
- Sysmex Company
- Horiba
- Bio-Rad Laboratories
- Siemens Healthcare
- F. Hoffman-L. One. Roche Limited
- mindray
- nihon kohen
- EKF Diagnostics
Main characteristics:
| record attribute | main points |
| refuse. of pages | 70 |
| forecast period | 2023 – 2030 |
| Estimated market value in 2023 (USD). | $2.12 billion |
| Estimated market value by 2030 (USD). | $3.07 billion |
| Compound Annual Value | 5.3% |
| lined area | United States of america |
Major topics lined up:
Bankruptcy 1. Method and scope
Bankruptcy 2. Official Summary
2.1. Marketplace Outlook
2.2. branch outlook
2.3. offensive insight
Bankruptcy 3. US Hematology Diagnostics Marketplace Variables, Characteristics and Scope
3.1. Marketplace Lineage Outlook
3.1.1. Mom or Dad Marketplace Outlook
3.1.2. Cognate/Subsidiary Market Outlook
3.2. market dynamics
3.2.1. Marketplace Motive Force Research
3.2.2. market restraint research
3.3. US Hematology Diagnostics Marketplace Research Tools
3.3.1. Business Research – Porter’s
3.3.2. pastel research
Bankruptcy 4. US Hematology Diagnostics Marketplace: Product Estimation and Development Research
4.1. Generation Marketplace Ratio, 2023 and 2030
4.2. branch dashboard
4.3. US Hematology Diagnostics Marketplace via Product Outlook
4.4. Marketplace Measurement and Forecast and Growth Analysis for the Following, 2018 to 2030
4.4.1. tool
4.4.1.1. Marketplace Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.1.2. hematology analyst
4.4.1.2.1. Marketplace Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.1.2.2. Medical laboratory testing hematology analyzers
4.4.1.2.2.1. Marketplace Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.1.2.2.2. Trying out the level-of-offer hematology analyzer
4.4.1.2.2.3. Marketplace Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.1.3. current cytometer
4.4.1.3.1. Marketplace Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.1.4. slide stainer/marker
4.4.2. consumables
4.4.2.1. Marketplace Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2.2. Reagents
4.4.2.3. Stain
4.4.2.4. controls and calibrators
Bankruptcy 5. US Hematology Diagnostics Marketplace: Check Types Estimates and Development Research
5.1. Check Type Market Ratio, 2023 and 2030
5.2. branch dashboard
5.3. US Hematology Diagnostics Marketplace via Check Kind Outlook
5.4. Marketplace Measurement and Forecast and Growth Analysis for the Following, 2018 to 2030
5.4.1. Check white blood cells (WBC)
5.4.2. Check Crimson Blood Cells (RBC)
5.4.3. hemoglobin test
5.4.4. hematocrit test
5.4.5. Serve as platelets
Bankruptcy 6. US Hematology Diagnostics Marketplace: Finish-Use Estimates and Development Research
6.1. Finish-use marketplace ratio, 2023 and 2030
6.2. branch dashboard
6.3. US Hematology Diagnostics Marketplace via Finish-Use Outlook
6.4. Marketplace Measurement and Forecast and Growth Analysis for the Following, 2018 to 2030
6.4.1. hospital
6.4.2. Diagnostic Labs
Bankruptcy 7. US Hematology Diagnostics Marketplace: Patch Estimates and Development Research
7.1. Regional Market Ratio, 2023 and 2030
7.2. US Hematology Diagnostics Marketplace via Patch Outlook
7.3. Marketplace Measurement and Forecast and Growth Analysis for the Following, 2018 to 2030
7.3.1. West
7.3.2. middle West
7.3.3. North east
7.3.4. Southwest
7.3.5. Southeast
Bankruptcy 8. Offensive Ground
8.1. Latest trends and impact research through key market members
8.2. Corporate/Festival Classification
8.3. Dealer Ground
8.3.1. Records of key vendors and channel partners
8.3.2. major consumers
8.3.3. Major Corporate Heat Map Research, 2023
8.4. Corporate Profile
8.4.1. corporate valuation
8.4.2. monetary efficiency
8.4.3. product benchmarking
8.4.4. strategic work
For more information about this record, consult https://www.researchandmarkets.com/r/f7b68u
About ResearchandMarkets.com
ResearchAndMarkets.com is the region’s leading source for global market analysis experiences and market information. We provide you with untapped information on world and regional markets, leading industries, dominating companies, untapped inventories and untapped developments.
-
US Hematology Diagnostics Marketplace